127 related articles for article (PubMed ID: 11680877)
21. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana M; Casu B; Lindahl U
J Biol Chem; 1994 Feb; 269(5):3903. PubMed ID: 8106436
[No Abstract] [Full Text] [Related]
22. The malaria circumsporozoite protein: interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate.
Ying P; Shakibaei M; Patankar MS; Clavijo P; Beavis RC; Clark GF; Frevert U
Exp Parasitol; 1997 Feb; 85(2):168-82. PubMed ID: 9030667
[TBL] [Abstract][Full Text] [Related]
23. Enzymatic Sequencing of Heparin Oligosaccharides Using Exolyase.
Zhang Q; Lu D; Li F
Methods Mol Biol; 2023; 2619():249-256. PubMed ID: 36662475
[TBL] [Abstract][Full Text] [Related]
24. Chemoenzymatic design of heparan sulfate oligosaccharides.
Liu R; Xu Y; Chen M; Weïwer M; Zhou X; Bridges AS; DeAngelis PL; Zhang Q; Linhardt RJ; Liu J
J Biol Chem; 2010 Oct; 285(44):34240-9. PubMed ID: 20729556
[TBL] [Abstract][Full Text] [Related]
25. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.
Hecht ML; Rosental B; Horlacher T; Hershkovitz O; De Paz JL; Noti C; Schauer S; Porgador A; Seeberger PH
J Proteome Res; 2009 Feb; 8(2):712-20. PubMed ID: 19196184
[TBL] [Abstract][Full Text] [Related]
26. Analysis of heparan sulfate oligosaccharides by nano-electrospray ionization mass spectrometry.
Pope RM; Raska CS; Thorp SC; Liu J
Glycobiology; 2001 Jun; 11(6):505-13. PubMed ID: 11445555
[TBL] [Abstract][Full Text] [Related]
27. Applications of heparin and heparan sulfate microarrays.
Yin J; Seeberger PH
Methods Enzymol; 2010; 478():197-218. PubMed ID: 20816481
[TBL] [Abstract][Full Text] [Related]
28. Labelling heparan sulphate saccharides with chromophore, fluorescence and mass tags for HPLC and MS separations.
Skidmore M; Atrih A; Yates E; Turnbull JE
Methods Mol Biol; 2009; 534():157-69. PubMed ID: 19277553
[TBL] [Abstract][Full Text] [Related]
29. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
[TBL] [Abstract][Full Text] [Related]
30. A novel computational approach to integrate NMR spectroscopy and capillary electrophoresis for structure assignment of heparin and heparan sulfate oligosaccharides.
Guerrini M; Raman R; Venkataraman G; Torri G; Sasisekharan R; Casu B
Glycobiology; 2002 Nov; 12(11):713-9. PubMed ID: 12460939
[TBL] [Abstract][Full Text] [Related]
31. Production of size-defined heparosan, heparan sulfate, and heparin oligosaccharides by enzymatic depolymerization.
Brown S; Kuberan B
Methods Mol Biol; 2015; 1229():21-9. PubMed ID: 25325940
[TBL] [Abstract][Full Text] [Related]
32. Highly diverse heparan sulfate analogue libraries: providing access to expanded areas of sequence space for bioactivity screening.
Yates EA; Guimond SE; Turnbull JE
J Med Chem; 2004 Jan; 47(1):277-80. PubMed ID: 14695842
[TBL] [Abstract][Full Text] [Related]
33. Divergent Synthesis of Heparan Sulfate Oligosaccharides.
Dulaney SB; Xu Y; Wang P; Tiruchinapally G; Wang Z; Kathawa J; El-Dakdouki MH; Yang B; Liu J; Huang X
J Org Chem; 2015 Dec; 80(24):12265-79. PubMed ID: 26574650
[TBL] [Abstract][Full Text] [Related]
34. Heparin sequencing.
Stringer SE; Kandola BS; Pye DA; Gallagher JT
Glycobiology; 2003 Feb; 13(2):97-107. PubMed ID: 12626406
[TBL] [Abstract][Full Text] [Related]
35. Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site.
Shriver Z; Raman R; Venkataraman G; Drummond K; Turnbull J; Toida T; Linhardt R; Biemann K; Sasisekharan R
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10359-64. PubMed ID: 10984531
[TBL] [Abstract][Full Text] [Related]
36. Heparin sequencing using enzymatic digestion and ESI-MSn with HOST: a heparin/HS oligosaccharide sequencing tool.
Saad OM; Leary JA
Anal Chem; 2005 Sep; 77(18):5902-11. PubMed ID: 16159120
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of depolymerized heparin SEC fractions: to pool or not to pool?
Eldridge SL; Korir AK; Gutierrez SM; Campos F; Limtiaco JF; Larive CK
Carbohydr Res; 2008 Nov; 343(17):2963-70. PubMed ID: 18804200
[TBL] [Abstract][Full Text] [Related]
38. Low-sulphated oligosaccharides derived from heparan sulphate inhibit normal angiogenesis.
Hahnenberger R; Jakobson AM; Ansari A; Wehler T; Svahn CM; Lindahl U
Glycobiology; 1993 Dec; 3(6):567-73. PubMed ID: 7510546
[TBL] [Abstract][Full Text] [Related]
39. Fractionation of heparin-derived oligosaccharides by gradient polyacrylamide-gel electrophoresis.
Rice KG; Rottink MK; Linhardt RJ
Biochem J; 1987 Jun; 244(3):515-22. PubMed ID: 3446173
[TBL] [Abstract][Full Text] [Related]
40. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
